- Home
- FORA vs INO Comparison
FORA vs INO Comparison
Compare FORA & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORA
- INO
- Stock Information
- Founded
- FORA 2014
- INO 1979
- Country
- FORA United States
- INO United States
- Employees
- FORA N/A
- INO N/A
- Industry
- FORA Computer Software: Prepackaged Software
- INO Medical/Dental Instruments
- Sector
- FORA Technology
- INO Health Care
- Exchange
- FORA Nasdaq
- INO Nasdaq
- Market Cap
- FORA 60.2M
- INO 69.3M
- IPO Year
- FORA N/A
- INO 1998
- Fundamental
- Price
- FORA $2.21
- INO $1.95
- Analyst Decision
- FORA Strong Buy
- INO Buy
- Analyst Count
- FORA 1
- INO 5
- Target Price
- FORA $5.00
- INO $8.80
- AVG Volume (30 Days)
- FORA 52.6K
- INO 1.8M
- Earning Date
- FORA 08-13-2025
- INO 08-12-2025
- Dividend Yield
- FORA N/A
- INO N/A
- EPS Growth
- FORA N/A
- INO N/A
- EPS
- FORA N/A
- INO N/A
- Revenue
- FORA $25,031,040.00
- INO $182,337.00
- Revenue This Year
- FORA $47.82
- INO N/A
- Revenue Next Year
- FORA $10.11
- INO $20,588.06
- P/E Ratio
- FORA N/A
- INO N/A
- Revenue Growth
- FORA 18.59
- INO N/A
- 52 Week Low
- FORA $1.64
- INO $1.30
- 52 Week High
- FORA $4.03
- INO $7.71
- Technical
- Relative Strength Index (RSI)
- FORA 65.42
- INO 66.17
- Support Level
- FORA $1.64
- INO $1.80
- Resistance Level
- FORA $2.04
- INO $2.06
- Average True Range (ATR)
- FORA 0.13
- INO 0.12
- MACD
- FORA 0.01
- INO 0.05
- Stochastic Oscillator
- FORA 53.27
- INO 80.88
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.